John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 3,725 shares at $1.89 ($7K) on 2022-06-28, disclosed to the SEC on 2022-06-29.
Scheduled sale ($7k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.89 | 2,725 | $5K | 75.0% |
| 2 | $1.72 | 1,000 | $2K | 25.0% |
| Total | $1.84 avg | 3,725 | $7K | 100% |
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |